CWK

Cushman & Wakefield plc NYSE

Real Estate ·Real Estate - Services ·GB · cushmanwakefield.com

$14.53

Mkt Cap $3.4B

52w Low $9.43 64.0% of range 52w High $17.40

50d MA $13.17 200d MA $14.85

P/E (TTM) 37.1x

EV/EBITDA 14.3x

P/B 1.7x

Debt/Equity 1.7x

ROE 4.5%

P/FCF 12.8x

RSI (14) —

ATR (14) —

Beta 1.49

50d MA $13.17

200d MA $14.85

Avg Volume 2.1M

About

Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East, and Africa; and Asia Pacific segments. It offers integrated facilities management, project and development, portfolio administration…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 19, 2026	AMC	0.53	-0.10	-118.5%	13.13	-0.4%	+1.5%	-1.5%	+3.4%	+4.8%	+5.5%	—
Oct 30, 2025	AMC	0.28	0.29	+3.6%	16.18	-1.2%	-3.0%	-3.7%	-3.4%	-4.2%	-4.7%	—
Aug 5, 2025	AMC	0.22	0.30	+36.4%	13.39	+0.0%	+2.1%	+0.0%	+2.2%	+0.8%	+6.1%	—
Apr 29, 2025	AMC	0.02	0.09	+350.0%	9.41	-1.6%	-0.4%	+2.0%	+7.1%	+6.4%	+4.6%	—
Feb 20, 2025	AMC	0.45	0.48	+6.7%	12.24	+0.7%	-4.9%	-4.1%	-3.1%	-1.9%	-2.8%	—
Nov 4, 2024	AMC	0.20	0.23	+15.0%	13.14	+5.0%	+15.4%	+11.3%	+13.2%	+13.5%	+14.8%	—
Jul 29, 2024	AMC	0.18	0.20	+11.1%	13.31	-2.1%	-3.6%	-1.5%	-4.6%	-6.8%	-10.3%	—
Apr 29, 2024	AMC	-0.06	-0.13	-100.0%	9.91	-2.9%	-2.6%	-3.0%	+0.0%	+1.1%	+2.1%	—
Feb 20, 2024	AMC	0.39	0.45	+15.4%	11.14	+1.3%	-10.2%	-10.1%	-11.8%	-13.1%	-11.8%	—
Oct 30, 2023	AMC	0.20	0.21	+5.0%	6.78	+2.4%	+8.7%	+10.6%	+12.7%	+21.8%	+19.5%	—
Jul 31, 2023	AMC	0.21	0.22	+4.8%	9.83	+0.9%	+4.2%	+3.2%	+2.8%	+5.0%	+6.0%	—
May 4, 2023	AMC	0.19	-0.04	-121.1%	8.94	-0.4%	-10.7%	-15.5%	-14.2%	-12.2%	-13.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 13	Barclays	Maintains	Equal Weight → Equal Weight	—	$11.89	$12.04	+1.3%	+2.1%	+4.0%	+4.9%	+4.2%	+2.0%
Nov 21	Citigroup	Upgrade	Neutral → Buy	—	$14.74	$15.39	+4.4%	+8.6%	+9.2%	+13.8%	+14.5%	+13.6%
Nov 12	Citigroup	Maintains	Neutral → Neutral	—	$15.93	$16.37	+2.8%	-0.1%	-2.5%	-2.8%	-7.3%	-7.2%
Nov 3	Citizens	Maintains	Market Outperform → Market Outperform	—	$15.70	$15.65	-0.3%	-0.8%	-0.4%	-1.3%	-1.8%	+0.2%
Oct 10	UBS	Maintains	Neutral → Neutral	—	$14.87	$15.09	+1.5%	-1.7%	+1.1%	+4.6%	+7.0%	+6.1%
Aug 26	JP Morgan	Maintains	Neutral → Neutral	—	$15.99	$16.00	+0.1%	-0.9%	-0.2%	-0.9%	-1.4%	-3.6%
Aug 13	Goldman Sachs	Maintains	Buy → Buy	—	$14.21	$14.40	+1.3%	+5.4%	+4.9%	+4.0%	+4.5%	+6.5%
Aug 8	Goldman Sachs	Upgrade	Sell → Buy	—	$13.39	$13.87	+3.6%	+2.2%	+0.8%	+6.1%	+11.9%	+11.4%
Aug 6	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$13.39	$13.39	+0.0%	+2.1%	+0.0%	+2.2%	+0.8%	+6.1%
Jul 2	UBS	Maintains	Neutral → Neutral	—	$11.39	$11.47	+0.7%	+2.3%	+4.0%	+1.8%	+0.5%	+0.8%
Jun 12	Morgan Stanley	Maintains	Overweight → Overweight	—	$10.65	$10.64	-0.1%	+1.4%	-2.3%	-0.3%	-3.7%	-2.3%
Apr 24	Morgan Stanley	Maintains	Overweight → Overweight	—	$8.52	$8.52	+0.0%	+5.2%	+3.3%	+5.8%	+10.4%	+10.0%
Apr 11	UBS	Maintains	Neutral → Neutral	—	$7.99	$7.84	-1.9%	+0.9%	+3.5%	+3.1%	+2.0%	+3.6%
Apr 10	JP Morgan	Maintains	Neutral → Neutral	—	$8.58	$8.24	-4.0%	-6.9%	-6.1%	-3.6%	-4.0%	-5.0%
Mar 19	Goldman Sachs	Maintains	Sell → Sell	—	$10.46	$10.51	+0.5%	+0.4%	+1.1%	-0.2%	+3.2%	+1.9%
Mar 17	Citigroup	Maintains	Neutral → Neutral	—	$10.69	$10.55	-1.3%	+0.3%	-2.2%	-1.8%	-1.1%	-2.3%
Feb 21	Goldman Sachs	Maintains	Sell → Sell	—	$12.24	$12.32	+0.7%	-4.9%	-4.1%	-3.1%	-1.9%	-2.8%
Jan 2	Jefferies	Downgrade	Buy → Hold	—	$13.08	$13.10	+0.2%	-3.7%	-2.0%	-1.8%	-6.0%	-6.8%
Dec 16	JP Morgan	Maintains	Neutral → Neutral	—	$14.87	$14.97	+0.7%	+1.0%	-1.7%	-10.1%	-12.9%	-12.0%
Jul 30	JP Morgan	Maintains	Neutral → Neutral	—	$13.31	$13.03	-2.1%	-3.6%	-1.5%	-4.6%	-6.8%	-10.3%
Jul 25	Raymond James	Maintains	Outperform → Outperform	—	$12.44	$12.60	+1.3%	+5.9%	+8.8%	+7.0%	+3.1%	+5.4%
Jun 21	JP Morgan	Maintains	Neutral → Neutral	—	$10.69	$10.69	+0.0%	+1.7%	-1.2%	-3.4%	-4.1%	-3.1%
Apr 9	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$10.98	$10.79	-1.7%	-3.4%	-7.7%	-9.8%	-10.0%	-12.8%
Apr 8	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$10.70	$10.86	+1.5%	+2.6%	-0.8%	-5.2%	-7.5%	-7.7%
Apr 3	Raymond James	Downgrade	Strong Buy → Outperform	—	$10.07	$9.77	-3.0%	+1.5%	+2.4%	+6.3%	+9.0%	+5.4%
Jan 25	Raymond James	Maintains	Strong Buy → Strong Buy	—	$9.97	$10.22	+2.5%	+3.6%	+3.6%	+6.7%	+7.1%	+5.5%
Dec 8	Wolfe Research	Upgrade	Peer Perform → Outperform	—	$8.61	$8.79	+2.1%	+3.3%	+3.4%	+2.6%	+12.4%	+23.2%
Nov 22	UBS	Maintains	Neutral → Neutral	—	$8.40	$8.53	+1.5%	+0.6%	+1.8%	-0.1%	+1.8%	-1.0%
Oct 31	Raymond James	Maintains	Strong Buy → Strong Buy	—	$6.78	$6.94	+2.4%	+8.7%	+10.6%	+12.7%	+21.8%	+19.5%
Oct 4	Raymond James	Maintains	Strong Buy → Strong Buy	—	$6.84	$6.80	-0.6%	-0.7%	+2.3%	+4.8%	+7.3%	+11.3%
Sep 18	Citigroup	Maintains	Neutral → Neutral	—	$8.27	$8.22	-0.6%	+0.6%	-1.0%	-2.8%	-10.8%	-8.7%
Aug 1	Raymond James	Maintains	Strong Buy → Strong Buy	—	$9.83	$9.92	+0.9%	+4.2%	+3.2%	+2.8%	+5.0%	+6.0%
Jul 24	Raymond James	Maintains	Strong Buy → Strong Buy	—	$9.95	$9.96	+0.1%	+0.9%	+1.1%	+3.2%	-4.4%	-3.0%
Jul 5	Morgan Stanley	Maintains	Overweight → Overweight	—	$8.30	$8.19	-1.3%	+0.4%	-2.4%	+0.0%	+2.9%	+8.0%
Jun 28	Citigroup	Maintains	Neutral → Neutral	—	$8.03	$7.98	-0.6%	-0.6%	+3.0%	+1.9%	+3.4%	+3.7%
May 19	Credit Suisse	Maintains	Neutral → Neutral	—	$8.11	$8.17	+0.7%	-3.1%	+0.6%	+0.5%	-3.6%	-4.6%
May 9	Goldman Sachs	Maintains	Neutral → Neutral	—	$7.55	$7.40	-2.0%	+1.6%	+4.0%	+2.8%	+0.7%	+2.0%
May 5	Raymond James	Maintains	Strong Buy → Strong Buy	—	$8.94	$8.90	-0.4%	-10.7%	-15.5%	-14.2%	-12.2%	-13.2%
Apr 17	UBS	Downgrade	Buy → Neutral	—	$9.51	$9.15	-3.8%	-0.4%	-1.7%	-0.9%	+0.1%	+1.3%
Apr 11	Goldman Sachs	Maintains	Neutral → Neutral	—	$9.60	$9.60	+0.0%	+1.4%	-0.2%	+0.8%	-0.9%	-1.4%
Apr 10	Goldman Sachs	Downgrade	Buy → Neutral	—	$9.85	$9.61	-2.4%	-2.5%	-1.2%	-2.7%	-1.7%	-3.5%
Feb 1	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$14.43	$14.12	-2.1%	-1.7%	+4.2%	+4.2%	+1.4%	+2.2%
Jan 27	Goldman Sachs	Maintains	Buy → Buy	—	$14.23	$14.14	-0.6%	+1.0%	-1.0%	+1.4%	-0.3%	+5.7%
Jan 20	Raymond James	Maintains	Strong Buy → Strong Buy	—	$13.75	$13.80	+0.4%	+2.3%	+3.5%	+1.9%	+1.4%	+3.5%
Nov 8	Goldman Sachs	Maintains	Buy → Buy	—	$10.78	$10.68	-0.9%	-2.4%	-3.8%	+5.1%	+11.4%	+5.7%
Nov 4	Raymond James	Maintains	Strong Buy → Strong Buy	—	$10.60	$10.04	-5.3%	-0.1%	+1.7%	-0.8%	-2.2%	+6.9%
Oct 20	Raymond James	Maintains	Strong Buy → Strong Buy	—	$11.16	$11.14	-0.2%	-0.8%	+3.0%	+2.1%	+5.0%	+7.5%
Oct 19	Goldman Sachs	Maintains	Buy → Buy	—	$11.86	$11.57	-2.4%	-5.9%	-6.7%	-3.1%	-4.0%	-1.2%
Jul 22	Raymond James	Maintains	Strong Buy → Strong Buy	—	$16.03	$16.01	-0.1%	-0.4%	-0.6%	-1.2%	+1.6%	+4.9%
Jul 6	Morgan Stanley	Maintains	Overweight → Overweight	—	$15.79	$15.65	-0.9%	-5.6%	-4.0%	-4.2%	-4.4%	-3.5%

Recent Filings

8-K · 8.01 !! High

Cushman & Wakefield plc -- 8-K 8.01: Material Event / Announcement

Cushman & Wakefield is redeeming $100 million of its $650 million outstanding 6.750% senior secured notes due 2028, reducing debt obligations ahead of maturity.

May 4

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

CWK disclosed material information via Regulation FD that won't be integrated into formal SEC filings, limiting its legal binding effect and potentially signaling management's preference to control narrative distribution to investors.

Apr 8

8-K · 7.01 ! Medium

Cushman & Wakefield Ltd. -- 8-K 7.01: Regulation FD Disclosure

Cushman & Wakefield will host an investor webcast on February 19, 2026, to discuss Q4 and full-year 2025 results with an accompanying presentation.

Feb 19

Data updated apr 25, 2026 4:19am · Source: massive.com